Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Evolutionary Behavioral Genomics of Drosophila Courtship
Prostaglandin Excretions in Preeclampsia
Neuropsychological Studies of Implicit Memory
Neurophysiology of Preganglionic Cardiac Motorneurons
Active Cannulas for Bio-Sensing and Surgery
Recently added grants:
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles
Molecular mechanisms by which mild elevation of mitochondrial superoxide extends lifespan
Protecting Privacy and Facilitating Shared Access of Clinical and Genetic Data of Special Populations
Determinants of prostate cancer sensitivity to PD-1 blockade
Lifestyle Intervention in Preparation for Pregnancy (LIPP)
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase II (N44)
Project #
N44CM027361-004
Application #
3609936
Study Section
Project Start
1992-08-01
Project End
1994-07-31
Budget Start
1993-06-30
Budget End
1994-07-31
Support Year
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Related projects
NIH 1993
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
NIH 1992
N44 CM
In Vitro Antineoplastic Drug Toxicology Characterization
Murphy, Martin / Hipple Cancer Research Corporation
Comments
Be the first to comment on Martin Murphy's grant